secwatch.observer — SEC 8-K summary
======================================

Issuer:     Progyny, Inc. (PGNY)
CIK:        0001551306
Form:       8-K
Filed at:   2024-02-27T23:59:59+00:00
Accession:  0001551306-24-000018
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Progyny reports record FY23 revenue $1.09B (+38%); guides FY24 $1.285-$1.315B
-----------------------------------------------------------------------------

- FY23 revenue $1,088.6M (+38% YoY); net income $62.0M ($0.62 diluted EPS), adj. EBITDA $187.1M (+49%).
- Q4 revenue $269.9M (+26%); net income $13.5M ($0.13 EPS); adj. EBITDA $43.2M (+31%).
- Clients grew to 392 as of Dec 31, 2023, from 288 a year earlier; expects >460 clients in 2024.
- FY24 revenue guidance $1.285-$1.315B (+18-21%), adj. EBITDA $224-$232M, adj. EPS $1.54-$1.59.
- Q1 2024 revenue guided $285-$292M (+10-13%); cites ~$15M headwind from short-term treatment mix shift.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551306/000155130624000018/0001551306-24-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551306/000155130624000018/pgny-20240227.htm
  HTML page:      https://secwatch.observer/filing/0001551306-24-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer